Home Seattle Genetics: 3 Reasons Why I Like This Midcap Biotech
 

Keywords :   


Seattle Genetics: 3 Reasons Why I Like This Midcap Biotech

2015-09-30 20:28:30| Biotech - Topix.net

Adcetris is in the midst of three Phase 3 and four Phase 2 trials to test its viability in treating other cancers and lymphoma. In the world of small- and mid-cap biotech companies it's often times a feast or famine proposition.

Tags: this reasons seattle genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06XREAL bring Play Store apps to 3D space on XREAL AR glasses
26.06Qwilt reveals live streaming survey results
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
More »